Article
Open Access
Volume 2 · Issue 2 · 2022
pp. 88–89
Infantile Hepatic Hemangioendothelioma with Complete Response to Propronalol Monotherapy
Özlem Terzi1, Hüseyin Avni Solğun1, Sümeyra Doğan2, Sibel Akpınar Tekgündüz1, Ali Ayçiçek1
1
Depertmant of Pediatric Hematology and Oncology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey
2
Depertmant of Pediatric Radiology, University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey
Abstract
Infantile Hepatic Hemangioendothelioma (IHH) is an extremely rare and painless vascular tumor. IHH is usually in benign nature but it can also be life-threatening with a rapid growth tendency. There are approaches in the treatment of IHH, ranging from drug therapy to liver transplantation. Propranolol, which is used in first-line therapy for most patients, is effective alone in the treatment.
Keywords: Infantile hepatic hemangioendothelioma, propranolol, massive hepatomegali
